|
Bausch & Lomb Incorporated |
|
|
One Bausch & Lomb Place Rochester, NY 14604-2701 USA phone:(585) 338-6000 fax:(585) 338-6007
|
|
| Symbol |
BOL |
| Exchange |
NYSE |
| Founded |
1853 |
| Employees |
|
|
|
| www.bausch.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Markets eye health products. |
 |
| Management |
| Dipankar Bhattacharjee Corporate Vice President and President ; Gerald M. Ostrov, Chairman, Chief Executive Officer; Sean D. Carney, Managing Director; Robert J. Palmisano, President, Chief Executive Officer; Elizabeth H. Weatherman, Managing Director |
| |
|
|
|
|
|
|
|
| Keywords |
| ophthalmic surgica, ophthalmic pharmaceuticals, beta blockers, conjunctivitis, steroid eye drops |
|
|
|
| Description |
|
It develops, manufactures and markets eye health products. It markets products in five product categories: contact lens, lens care, pharmaceuticals, cataract and vitreoretinal and refractive. The contact lens category includes traditional, planned replacement disposable, daily disposable, multifocal, continuous wear and toric soft lenses and rigid gas permeable lenses and materials. The lens care category includes multi-purpose solutions, enzyme cleaners and saline solutions. The pharmaceuticals category includes generic and proprietary prescription ophthalmic drugs, ocular vitamins, over-the-counter medications and vision accessories. The cataract and vitreoretinal category includes intraocular lenses, phacoemulsification equipment and related disposable products and viscoelastics and other products. The refractive category includes lasers, microkeratomes, diagnostic equipment and other products and equipment used in refractive surgery. |
 |
| Technology / Differentiation |
| Multiple technologies including: rPlasmin; recombinant technology, anti-angiogenesis, glucocorticoid receptor agonist. |
 |
| Market / Customers |
A wide variety of eye care pharmaceuticals.
|
 |
|
|
|
|
|
|